A major advantage of this form of monitoring is the ease of measurement involving a simple blood sample. The normal concentration is around 1 mEq. L -l. Experimental studies have shown that a decrease in oxygen delivery below a critical value is accompanied by a rise in lactate concentration. I Clinical studies also show that pathological oxygen uptake/supply dependency is associated with raised lactate. 2 Studies have also confirmed that blood lactate concentrations correlate well with outcome from circulatory failure. 3,4 The use of sequential measurements of lactate is of more importance than an isolated level in assessing tissue oxygenation and this can be easily achieved by the use of automated analysers. 5, 6 Limitations Blood lactate concentrations represent a good measure of tissue perfusion but they have several important limitations. First, the lactate level at any time is a balance between its production and elimination. Clearance occurs primarily in the liver and liver failure could cause abnormally high levels. Patients with stable cirrhosis seem to maintain relatively normal concentrations but, nevertheless, the presence of liver disease can magnify levels raised because of circulatory failure and delay their return to normal once resuscitation is complete.
Second, blood lactate concentrations are raised not only in hypoxia associated with acute circulatory failure but also in certain cellular metabolic defects and during seizures (Table I) . Fortunately, except for seizures, these other conditions are relatively rare and all are fairly easily recognized. Third, in animal studies, increased lactate production may occur in the presence of endotoxin, even in the absence of tissue hypoxia. 7 
Summary
Despite these drawbacks, blood lactate concentrations can provide a valuable guide to tissue hypoxia and levels >1.5 to 2 mEq-L -l should alert the clinician to the possibility of reduced tissue oxygenation. However, they are a fairly general guide of global tissue hypoxia and the possibilities of a more local measure of tissue hypoxia are interesting.
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Gastric intramucosal pH (pHi)
The measurement of pHi was first devised in 19818 but its use as a monitor in critically ill patients was not seriously considered until five years later. It has been postulated that gut ischaemia may increase bacterial translocation, thus stimulating the cascade of inflammatory mediators leading ultimately to multiple organ failure. The selective reduction in blood flow to the coeliac, mesenteric and hepatic circulations in low cardiac output states makes the potential of a local measure of gut tissue perfusion valuable as an early warning signal.
Advantages
Basically, this minimally invasive technique involves passing a nasogastric tube with a CO2 permeable balloon at its tip into the gastric lumen. The balloon is filled with saline, the CO2 allowed to equilibrate with that in the mucosa, and the saline then aspirated for PCO2 analysis. The pHi is then calculated using the Henderson-Hasselbach formula:
where C is a constant value, HCO3-the bicarbonate concentrate in arterial blood and the PCO2 the tension in the balloon. A normal pHi indicates that the stomach, and hence the splanchnic circulation, is adequately oxygenated, whilst a low pHi suggests inadequate splanchnic oxygenation.
Studies confh'm the ability of pHi to detect intestinal mucosal ischaemia 9 and its correlation with other measures of tissue hypoxia such as blood lactate. It is a more sensitive indicator and is able to detect ischaemia in patients who appear by other global haemodynamic measurements to be adequately oxygenatedJ ~ Low pHi levels have also been shown to correlate with increased mortality in intensive care unit patients.ll,12
Limitations
The measurement of pHi is based on two assumptions: first, that the PCO2 in the saline is the same as that in the tissues and second, that the arterial blood bicarbonate concentration is the same as that in the gastric mucosa. It also has its limitations. Technically, the measurement process is time consuming and requires considerable care. A time lapse of 30 to 90 min is required after instilling the saline in the balloon before measurements can be taken, to allow for equilibration of gases and pHi. Monitoring must therefore, be intermittent. Several factors can potentially influence pHi levels including CO2 generating antacids, enteral nutrition and changes in gastric acid secretion. It has been suggested that ranitidine should be administered to patients undergoing pHi measurement to limit this last effect. 13 The calculation of pHi using arterial bicarbonate concentrations makes it partially dependent on systemic acid-base balance.
Therefore, pHi represents a valuable tool for local assessment of impaired tissue perfusion. Further study needs to be done to define a normal value but the majority of studies are currently using 7.35 or 7.32 as a lower normal limit. Technical difficulties and the time lapse required between measurements have led to the suggestion of another, simpler measure, that of regional PCO2.
Regional PCO2 (PrCO2)
The equilibrium of mucosal and intraluminal PCO 2 has been well documented experimentally 14 and this property of CO2 diffusion can be employed to simplify the measure of pHi. If the balloon at the tip of the nasogastric tube is insufflated with air, the PCO2 measured in this will reflect the gastric PrCO2. This will be influenced by PaCO2 and blood gas measurements still need to be taken. An alternative would be to measure, simultaneously with the PrCO2, the PCO2 of the expired air (end-tidal CO2 or PETCO2) and to calculate the difference (PrCO2 -PETCO2). 15 This measurement avoids the technical problems and calculations associated with pHi measurement, obtains a value independent of systemic bicarbonate concentration and can be an almost continuous monitor of tissue perfusion (Table II) .
Combination monitoring
Each monitoring technique has its positive and negative aspects. Rather than spending time arguing the benefits of any one indicator, the most effective and reliable assessment of tissue perfusion will be achieved by using a combination of several methods. This approach is sup- 
Conclusion
The detection of altered tissue perfusion and hence reduced oxygenation is predictive of mortality. Therefore a reliable technique, available for use at the bedside of every critically ill patient, is required to enable early accurate identification of inadequate oxygenation. A combination of systemic and regional measures is likely to give the most reliable assessment of a patient's condition, and continuous or at least regularly repeated measurements, in addition to clinical evaluation, are necessary to give an accurate picture, enabling appropriate treatment to be instituted and its effects monitored.
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Monitorage de la perfusion tlssulalre
Jean-Louis Vincent MD PhD L'hypoxie tissulaire repr6sente un 616ment important dans la pathog6n6se de la d6faillance multivisc6rale. L'habilet6 ~t mesurer efficacement et ~ monitorer la perfusion tissulaire est donc importante pour l'6valuation et le traitement du malade en phase critique. Il devient de plus en plus 6vident que les mesures de l'oxyg6nation syst6mique monitorisent pauvrement la perfusion r6gionale. C'est ce qui explique la recherche actuelle de nouvelles m&hodes d'6valuation de l'oxyg6nation tissulaire plus fiables qui compl6teront les param6tres globaux. Pour que ces techniques soient applicables, elles doivent ~rre couramment r~pandues, accessibles ~t un coot relativement modique, peu effractives et faciles /~ utiliser.
La saturation du sang veineux m~l~ (SV02)
La saturation du sang veineux m~16 constitue un param~tre de la relation entre l'utilisation et l'apport en oxyg~ne mais elle ne mesure pas directement l'oxygtnation tissulaire. Certaines conditions comme le sepsis, les traumatismes et la chirurgie prolongte, l'alttration de la capacit6 d'extraire l'oxyg~ne tissulaire peuvent limiter son utilisation courante, car dans ces conditions, l'interprttation de la SVO2 s'avtrera difficile. La mesure de la SvO2 est peu effractive mais ntcessite tout de m~me l'insertion d'un cathtter de S~van-Ganz. Elle est intermittente si on prtl~ve destchantillons du sang veineux m816 de l'arttre pulmonaire, ou continue, si on utilise un cathtter de Swan-Ganz modifi6 muni de fibres optiques. Pour le patient en phase critique, la valeur normale se situe ~ 70% environ. La mesure de la SVO2 constitue une 616ment important du monitorage htmodynamique en phase critique mais il existe des indicateurs plus sptcifiques de la perfusion fissulaire. Ceux-ci peuvent nous fournir des renseignements suppltmentaires de grande valeur.
La concentration de lactate
Le lactate est le rtsultat du mttabolisme glucidique dont l'aboutissement final est le pyruvate. A son tour, la dtgradation du pyruvate emprunte une de trois voies mttaboliques. L'hypoxie tissulaire induit le mttabolisme anatrobique avec augmentation de la production de lactate par rtduction du pyruvate par la nicotinamide adtnine dinucltotide avec mtdiation par la d6shydrogt-nase lactique. 
Avantages
Le pH gastrique intramuqueux (pHi)
La mesure du phi a 6t6 introduite en 19818 mais son utilisation comme moniteur du patient en phase critique n'a 6t6 s6rieusement envisag6 que cinq ans plus tard. On a postul6 que l'isch6mie intestinale pouvait augmenter la translocation bact6rienne et ainsi stimuler la cascade des m6diateurs inflammatoires et provoquer ultimement une d6faillance multivisc6rale. Dans les 6tats de bas d6bits cardiaques, la r6duction s61ective du d6bit sanguin aux circulations coeliaque, m6sent6rique et h6pa-tique confirme le potentiel de l'efficacit6 de la mesure de la perfusion tissulaire intestinale comme signal d'alerte prtcoce.
Avantages
Cette technique est tr~s peu effractive et ntcessite l'introduction dans la lumi~re gastrique d'un tube nasal posstdant ~ son extrtmit6 un ballonnet permtable au CO2. Le ballonnet est rempli de solut6 physiologique, on laisse le CO2 s'tquilibrer avec celui de la muqueuse et le solut6 physiologique est alors aspir6 pour l'analyse de la PCO 2. Le pHest alors calcul6 avec l'tquation de Henderson-Hasselbach:
o~ C est une constante, HCO 3-la concentration art~rielle de bicarbonate et PCO 2 le niveau final mesur6 dans le ballon. Un pHi normal indique que l'estomac et, par constquent, la circulation splanchnique est adtquatement oxygtnte; par contre, un pHi abaiss6 sugg~re une insuffisance de l'oxygtnation splanchnique. Des 6tudes confirment la capacit6 du pHi 9 ~ dtceler l'ischtmie de la muqueuse intestinale et sa corrtlation avec d'autres mesures d'hypoxie tissulaire comme le lactate sanguin. I1 ~'agit d'un indice plus sensible et capable de dttecter l'ischtmie chez des patients qui semblent bien oxygtnts si on se fie h d'autres mesures htmodynamiques globales. 1~ Les baisses de pHi sont aussi en corrtlation avec l'augmentation de la mortalit6 chez les patients hospitalists en unit6 de soins intensifs.ll, 12
Limites
La mesure du phi repose sur deux suppositions: premi~rement, que la PCO 2 du solut6 physiologique est la m~me que celle des tissus, et deuxi~mement, que la concentration du bicarbonate arttriel est la m~me que la celle de la muqueuse gastrique. Cette m&hode a aussi ses limites. Techniquement, elle consomme du temps et ntcessite beaucoup de minutie. Un intervalle de 30 ~ 90 minutes est requis apr~s l'instillation du solut6 physiologique dans le ballonnet et pour permettre au gaz et au pH de s'tquilibrer avant qu'on puisse prendre la mesure. Le monitorage ne peut donc ~tre qu'intermittent. Plusieurs facteurs peuvent influencer les niveaux du pHi dont les antiacides qui lib~rent du CO2, l'alimentation parenttrale et les variations de la stcrttion d'acide gastrique. On a suggtr6 d'administrer de la ranitidine aux patients chez qui on mesure le pHi pour limiter ce dernier effet) 3 L'utilisation de la concentration de bicarbonate arttriel pour le calcul du pHi rend le rtsultat partiellement.dtpendant de l'tquilibre acido-basique systtmique.
Le pHi reprtsente donc un outil valable pour 6valuer la dtficience de la perfusion tissulaire. I1 faudra rtaliser d'autres 6tudes pour d6finir une valeur normale mais la majorit6 des 6tudes actuelles mentionnent 7,35 ou 7,32 comme limite inftrieure de la normale. Les difficultts techniques et l'intervalle de temps requis entre les mesures a permis de croire qu'une mesure plus simple serait prtftrable, celle du PCO2 rtgional.
Le PCO 2 r~gional (PrC02)
L'tquilibre entre la PCO 2 de la muqueuse et celle de la lumi~re gastrique a 6t6 bien documentte en laboratoire. 14 La capacit6 de diffusion du CO 2 peut servir/~ simplifier, la mesure du pHi. Si le ballonnet situ6 ~ l'extrtmit6 du tube nasogastrique est gonfl~ avec de l'air, la mesure de la PCO2 du ballonnet refl6tera la PrCO2 gastrique. Comme celle-ci subit l'influence de la PaCt2, il est 6vident que l'analyse des gaz arttriels sera requise. Toutefois, on peut aussi mesurer simultan6ment avec la R60 
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PrCO2, la PCO2 de l'air expir6 (la CO2 ttlt-expiratoire ou PE'rCO2, et calculer la difftrence (PrCO2 -PETCO2)). 15 Cette fagon de mesurer nous permet de contourner les difficultts techniques et les calculs associts avec la mesure du pHi, procure une valeur indtpendante du bicarbonate systtmique et constitue un monitorage quasi continu de la perfusion tissulaire (Tableau II).
Le monitorage combin6
Chaque 
Conclusion
La dttection des alttrations de la perfusion tissulaire et, par constquent, de la baisse de l'oxyg6nation est pronostique de la mortalitt. Une technique fiable et r6a-lisable au lit du patient en phase critique est requise pour l'identification prtcoce et prtcise de l'insuffisance de l'oxyg~nation tissulaire afin d'intervenir pour limiter
